AG0019YR

138982-67-9 | 2H-Indol-2-one, 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-, hydrochloride, hydrate (1:1:1)

AG0019YR

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	138982-67-9
Catalog Number	AG0019YR(AGN-PC-0PNMUS)
Chemical Name	2H-Indol-2-one, 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-, hydrochloride, hydrate (1:1:1)
IUPAC Name	5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one;hydrate;hydrochloride
InChI	InChI=1S/C21H21ClN4OS.ClH.H2O/c22-17-13-18-15(12-20(27)23-18)11-14(17)5-6-25-7-9-26(10-8-25)21-16-3-1-2-4-19(16)28-24-21;;/h1-4,11,13H,5-10,12H2,(H,23,27);1H;1H2
InChI Key	ZCBZSCBNOOIHFP-UHFFFAOYSA-N
MDL Number	MFCD00921885
Molecular Formula	C21H24Cl2N4O2S
Molecular Weight	467.4119
SMILES	O.Cl.S1N=C(C2=C1C=CC=C2)N2CCN(CC2)CCC=2C=C1CC(NC1=CC2Cl)=O
UNII	216X081ORU
Synonyms	5-(2-(4-(3-benzisothiazolyl)piperazinyl)ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one, CP 88059, CP 88059-01, CP-88,059, CP-88,059-01, CP-88,059-1, Geodon, ziprasidone, ziprasidone hydrochloride, ziprasidone hydrochloride, monohydrate, ziprazidone, 138982-67-9, Ziprasidone hydrochloride monohydrate, Ziprasidone hydrochloride, Geodon, 5-(2-(4-(Benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one hydrochloride hydrate, Ziprasidone HCl hydrate, UNII-216X081ORU, MFCD00921885, Ziprasidone hydrochloride [USAN:USP], Ziprasidone (hydrochloride monohydrate), CP-88059, CP 88,059-1, 216X081ORU, Zeldox, Ziprasidone hydrochloride [USAN], Geodon (TN), ZIPRASIDONE HYDROCHLORIDE HYDRATE, 5-(2-(4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-2-indolinone monohydrochloride, monohydrate, C21H21ClN4OS.HCl, CHEBI:32314, Ziprasidone hydrochloride (USAN), 2H-Indol-2-one, 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-, monohydrochloride, monohydrate, 5-[2-[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride monohydrate, NCGC00186050-01, CP 88059, CP-880591, CP 88059-1, CP-88,059-1, zlchem 4, 5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one;hydrate;hydrochloride, AC1Q3ESV, Ziprasidone HCl monohydrate, Geodon Hydrochloride Hydrate, SCHEMBL122875, AC1L1U24, CHEMBL1375743, CTK8B7827, C21H21ClN4OS.HCl[H2O], DTXSID00160855, SYN3019, ZLA0004, ZCBZSCBNOOIHFP-UHFFFAOYSA-N, Tox21_501025, ANW-58715, CZ0015, GP6084, ziprasidone hydrochloride, monohydrate, AKOS015961662, AN-9382, API0004648, CCG-222329, CS-1198, LP01025, ME-2112, RTR-031719, TRA0084802, Ziprasidone hydrochloride hydrate (JAN), NCGC00261710-01, AK-75766, AS-16359, BC207663, HY-17407, LS-173039, TR-031719, 4CH-021473, FT-0600387, ST24044165, CP-88059-01, CP 88-059-01, D01939, 982Z679, C-35605, J-007206, Ziprasidone hydrochloride monohydrate, >=98% (HPLC), solid, Ziprasidone for system suitability 1, European Pharmacopoeia (EP) Reference Standard, Ziprasidone for system suitability 2, European Pharmacopoeia (EP) Reference Standard, Ziprasidone Hydrochloride Monohydrate 1.0 mg/ml in Methanol (as anhydrous free base), Ziprasidone hydrochloride monohydrate, European Pharmacopoeia (EP) Reference Standard, Ziprasidone hydrochloride, United States Pharmacopeia (USP) Reference Standard, 2H-Indol-2-one, 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-, hydrochloride, hydrate (1:1:1), 2H-Indol-2-one,5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl_ethyl)-6-chloro-1,3-dihydro-monohydrochloride,monohydrate, 5-[2-[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one Hydrochloride Monohydrate, CP-88059-1, 5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one hydrate hydrochloride, 5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-indolin-2-one hydrate hydrochloride, Ziprasidone HCl, Ziprasidone, Ziprasidone mesylate, C21H21ClN4OS.ClH.H2O, CID60853, C21-H21-Cl-N4-O-S.Cl-H.H2-O, 3107H, 146939-27-7, 5-[2-[4- -1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-onehydrochloride, 122883-93-6, 2H-Indol-2-one, 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-, monohydrochloride, monohydrate, 5-[2-[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride, 5-[2-[4-(1,2-Benzisothiazol-3yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride,

Complexity	573
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	3
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	466.1g/mol
Formal Charge	0
Heavy Atom Count	30
Hydrogen Bond Acceptor Count	6
Hydrogen Bond Donor Count	3
Isotope Atom Count	0
Molecular Weight	467.409g/mol
Monoisotopic Mass	466.1g/mol
Rotatable Bond Count	4
Topological Polar Surface Area	77.7A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class	6.1
Hazard statements	H317-H373
Packing Group	Ⅲ
Precautionary statements	P260-P280-P333+P313
UN Code	UN 2811

Certificate of Analysis

Lot Number